Physician profile
Lea Harracksingh
NPI 1679560007
$3,987.54
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,600 · 2020: $946 · 2021: $98.12 · 2022: $227 · 2023: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $115.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $710.92 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $531.34 | 2019-2023 | Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $334.80 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $310.76 | 2019-2020 | |
| Lilly USA, LLC | $276.74 | 2019-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $268.56 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Kowa Pharmaceuticals America, INC. | $255.17 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $172.56 | 2019-2020 | |
| Amgen INC. | $170.26 | 2019-2021 | |
| Pfizer INC. | $169.48 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $168.91 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $127.10 | 2019-2020 | |
| Amarin Pharma, INC. | $114.46 | 2019-2020 | |
| Astellas Pharma US INC | $88.44 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $84.94 | 2019-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $55.23 | 2019-2020 | |
| Glaxosmithkline, LLC. | $49.44 | 2020-2023 | Trelegy Ellipta, Arexvy |
| Radius Health, INC. | $38.26 | 2019 | |
| Philips North America LLC | $36.53 | 2019 | |
| Esperion Therapeutics, INC. | $23.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lea Harracksingh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.